Bertagnolli confirmed as NIH director

The U.S. Senate has confirmed Monica Bertagnolli as NIH director, although time is short for her to leave a positive legacy with only a year to go until the next presidential election. A BioCentury Editor’s Commentary recently identified three ways Bertagnolli could improve NIH by 2025: fix the postdoc crisis, rebuild trust in NIH and identify her successor at NCI, where she succeeded Ned Sharpless as director in October 2022. Unless President Joe Biden wins a second term or his successor keeps her in place, Bertagnolli would be the shortest-serving Senate-confirmed NIH director since the position became a presidential appointment in 1971. Her confirmation was delayed by Sen. Bernie Sanders (I-Vt.), as part of a protest of prescription drug prices. 

Diaccurate S.A., hired Scott Filosi to succeed Dominique Bridon as CEO and changed its name to Evexta Bio S.A. Filosi was CEO of Luzsana Biotechnology Inc. and Mirror Biologics Inc. Bridon will become CSO. ...